A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)
Completed · Phase 1
Conditions studied: Healthy
In brief
The goal of the study is to learn what happens to enlicitide decanoate in a healthy person's body over time when taken on an empty stomach or with food. Researchers will compare what happens to enlicitide in a healthy person's body over time when enlicitide is taken with or without food. Enlicitide decanoate will be referred to as "enlicitide" throughout.
Key facts
- Study ID
- NCT06609512
- Run by
- Merck Sharp & Dohme LLC
- People needed
- 20
- Starts
- 2024-10-21
- Expected to finish
- 2025-01-31
- Last updated by the study team
- 2025-02-07
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- The main inclusion criteria include but are not limited to the following:
- Has body mass index (BMI) ≥18 kg/m\^2 and ≤32 kg/m\^2
You may not qualify if…
- The main exclusion criteria include but are not limited to the following:
- History of gastrointestinal disease which may affect food and drug absorption, or has had a gastric bypass or similar surgery
- History of cancer (malignancy)
- Positive test(s) for Hepatitis B surface antigen (HBsAg), hepatitis C antibodies or Human immunodeficiency virus (HIV)
- History of a major surgery
- Is lactose intolerant
Where it is running
- Celerion ( Site 0001) — Tempe, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.